Sickle Cell Disease Comprehensive Visit Note

Visit Details

Date: [date of service]

Patient: [name, MRN, DOB]

Clinician: [name and role]

Visit Type: [in-person / telehealth; interpreter if used]

Visit Purpose: [comprehensive SCD follow-up / other stated purpose]

SCD Safety Summary

(Keep compact and scannable. Use explicit unknown-status placeholders with actions when data are missing.)

• Genotype: [confirmed genotype with source and date / Unconfirmed—verification pending] (If unconfirmed, specify action to obtain.)
• Baseline Hemoglobin: [steady-state hemoglobin range and when established / Unknown—baseline not established]
• Key Complications: [brief list of major SCD complications with current status and key dates] (If none, state "None to date.")

Transfusion/Blood Bank (safety-critical—never leave blank)

• RBC antigen profile: [phenotype/genotype with date / Not on file—needs completion]
• Alloantibodies: [list with date last confirmed / None identified (date) / Unknown—records requested]
• Prior reactions: [DHTR/hyperhemolysis history with dates / None documented / Unknown—verify with blood bank]
• Matching requirements: [current matching protocol / Unknown—coordinate with blood bank]

Pain Plan Summary

• Home regimen: [first-line and escalation medications; bowel regimen / Unknown—clarify today]
• Acute care plan: [individualized ED protocol and dosing; where plan is stored / Not established—create and distribute]
• Naloxone: [Yes—prescribed (date) / No—not on opioids / No—prescribe today]

Current Disease-Modifying Therapy: [medication, dose, start date, adherence summary / Not currently on DMT—reason and plan to revisit]

Devices: [port/catheter status, site, last access] (Omit if no device present.)

Interval History

[Brief narrative summary of course since last visit, anchored to dates, highlighting key events and responses to therapy]

• SCD Events: [VOC count by setting (home vs ED vs admission); ACS episodes; transfusions with dates/type/indication; infections; procedures; new neurologic symptoms]
• Pain Status: [baseline pain pattern; functional impact; response to home regimen; adherence or access concerns]
• Therapy Monitoring: [DMT adherence and adverse effects; chelation adherence if applicable]
• Psychosocial/Functional: [school/work attendance; mood; barriers to care] (Only include if clinically relevant updates.)

Objective

Vitals: [BP, HR, Temp, RR, SpO2, weight, pain score]

Exam: [focused findings by system as relevant to SCD—general appearance, cardiopulmonary, abdominal, neuro screen, skin/extremities] (Include only pertinent positives and negatives.)

Data Review: [relevant labs (CBC with retic, CMP, hemolysis markers, HbF/MCV if on hydroxyurea, iron studies if transfused), imaging, and screening results with dates and brief interpretation] (If required monitoring labs for a therapy are missing, explicitly state this and document mitigation plan.)

Assessment & Plan

[Age]-year-old with [genotype] SCD complicated by [major complications], on [current therapy], here for [visit purpose]; interval notable for [key events].

SCD Disease Control & Therapy

[Status of disease control; VOC frequency trend; response to current DMT; plan to continue/adjust/escalate with rationale; monitoring schedule and next labs due; if not on DMT, document reason and revisit plan; shared decision-making notes for major therapy decisions]

Pain Management

[Adequacy of home plan; adjustments to regimen; non-pharmacologic strategies; acute care plan updates and accessibility; if on chronic opioids: functional benefit, risk mitigation measures, naloxone status]

Transfusion Plan

[Current indication and schedule if on transfusion program; upcoming needs and targets; blood bank coordination; if no transfusions planned, state reassessment criteria]

Organ Complications

[Address only active or monitored complications—cerebrovascular/TCD, pulmonary, renal/proteinuria, ophthalmologic, AVN, priapism, leg ulcers as applicable; include current status and management plan for each] (Omit organ systems without active issues.)

Preventive Care

[Immunization status; screening due dates (TCD, urine protein, dilated eye exam, depression screen); infection prevention including fever threshold for urgent evaluation; penicillin prophylaxis status if pediatric]

Care Coordination

[Referrals placed; outside records to obtain; transition planning if adolescent; SDOH barriers and mitigation; reproductive counseling status if applicable]

Follow-up

Next Appointment: [interval and rationale]

Return Precautions: [criteria for earlier return—increased VOCs, fever threshold, new neurologic or respiratory symptoms]

Orders Placed: [labs, imaging, referrals, medication changes]

(For any missing safety-critical information—genotype, alloantibodies, transfusion reaction history, current opioid regimen—use explicit unknown-status placeholders and document action to obtain rather than leaving blank.)